![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Kurch, L.; Hasenclever, D.; Kluge, R.; Georgi, T.; Tchavdarova, L.; Golombeck, M.; Sabri, O.; Eggert, A.; Brenner, W.; Sykora, K. W.; Bengel, F. M.; Rossig, C.; Koerholz, D.; Schäfers, M.; Feuchtinger, T.; Bartenstein, P.; Ammann, R. A.; Krause, T.; Urban, C.; Aigner, R.; Gattenloehner, S.; Klapper, W. und Mauz-Koerholz, C.
(2019):
Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET >= 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.
In: Pediatric Blood & Cancer, Bd. 66, Nr. 3, e27539
Bökstegers, A.-M.; Bläschke, F.; Schmid, I.; Wiebking, V.; Immler, S.; Hoffmann, F.; Bochmann, K.; Müller, S.; Grünewald, T. G. P.; Feucht, J. und Feuchtinger, T.
(2017):
MRD response in a refractory paediatric T-ALL patient through anti-programmed cell death 1 (PD-1) Ab treatment associated with induction of fatal GvHD.
In: Bone Marrow Transplantation, Bd. 52, Nr. 8: S. 1221-1224
Lee, D. W.; Wayne, A. S.; Huynh, V.; Handgretinger, R.; Pieters, R.; Michele, G.; Baruchel, A.; Feuchtinger, T.; Bertrand, Y.; Hemiston, M.; Brown, P. A.; Rossi, J.; Jiang, Y.; Navale, L.; Stout, S.; Aycock, J.; Mardiros, A.; Wiezorek, J. und Jain, R.
(2017):
ZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).
In: Annals of Oncology, Bd. 28
Döring, M.; Cabanillas Stanchi, K. M.; Queudeville, M.; Feucht, J.; Schlegel, P.; Feuchtinger, T.; Lang, P.; Müller, I.; Handgretinger, R. und Heinz, W. J.
(2016):
Antifungal prophylaxis with posaconazole suspension versus tablet in pediatric patients after hematopoietic stem cell transplantation.
In: International Journal of Infectious Diseases, Bd. 45: S. 312
Kontny, U.; Franzen, S.; Behrends, U.; Bührlen, M.; Christiansen, H.; Delecluse, H.; Eble, M.; Feuchtinger, T.; Gademann, G.; Granzen, B.; Kratz, C. P.; Lassay, L.; Leuschner, I.; Mottaghy, F. M.; Schmitt, C.; Staatz, G.; Timmermann, B.; Vorwerk, P.; Wilop, S.; Wolff, H. A. und Mertens, R.
(2016):
Diagnosis and Treatment of Nasopharyngeal Carcinoma in Children and Adolescents - Recommendations of the GPOH-NPC Study Group.
In: Klinische Padiatrie, Bd. 228, Nr. 3: S. 105-112
Babor, F.; Peters, C.; Sauer, M.; Manser, A.; Mytilineos, J.; Horn, P.; Ahlmann, M.; Oevermann, L.; Guengoer, T.; Strahm, B.; Gruhn, B.; Stachel, D.; Woessmann, W.; Cario, G.; Mueller, I.; Scherenschlich, N.; Pichler, H.; Feuchtinger, T.; Mezger, M.; Bader, P.; Borkhardt, A.; Uhrberg, M. und Meisel, R.
(2016):
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improves leukemia control after stem cell transplantation for childhood ALL.
In: Bone Marrow Transplantation, Bd. 51:
S41-S42
Lang, P.; Eichholz, T.; Feuchtinger, T.; Teltschik, H.-M.; Mueller, I.; Pfeiffer, M.; Schumm, M.; Ebinger, M.; Schwarze, C.-P.; Gruhn, B.; Alten, J.; Albert, M.; Greil, J.; Urban, C. und Handgretinger, R.
(2016):
Final results of a multicenter phase I/II study using CD3/CD19 depleted stem cells for haploidentical transplantation in children.
In: Bone Marrow Transplantation, Bd. 51:
S463-S464
Teltschik, H.-M.; Gruhn, B.; Feuchtinger, T. und Urban, C.
(2016):
Haploidentical stem cell transplantation (SCT) with t cell depleted grafts in advanced pediatric sarcomas.
In: Bone Marrow Transplantation, Bd. 51:
S265-S266
Malaval, C.; Feucht, J.; Doering, M.; Stanchi, K. M. Cabanillas; Teltschik, H. M.; Mueller, I.; Handgretinger, R.; Lang, P. und Feuchtinger, T.
(2016):
A treosulfan-based toxicity-reduced conditioning regimen is safe and feasible for children with non-malignant diseases but increases rejection rates in stem cell transplantation of hemoglobinopathies.
In: Haematologica, Bd. 101: S. 635-636